Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplified and Decentralized Hepatitis C Treatment in Primary Health Care in Brazil
NCT06306300Phase 4Recruiting
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Jul 2022
- Primary completion
- Dec 2026
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir, velpatasvir in hepatitis C (HCV), sponsored by Fundação Oswaldo Cruz. Started Jul 2022; status: recruiting.
02
Drugs
sofosbuvirvelpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT06306300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306300.